A collection of the many biographies of scientist Isaac Newton, demonstrating the ways in which his reputation continued to develop in the centuries after his death. It includes private letters, poetry and memoranda, and explores the debate over Newton's reputation, work and personal life.
The pharmaceutical and healthcare industry is hugely complex because it involves so many markets, products, processes and intermediaries. It is also heavily regulated, global, and used by everyone at some stage in their life. No wonder the supply chain for delivery of healthcare services is often fragmented and understood only in discrete sections. Changes in one area impact upon the others, and environmental factors such as pricing, regulatory change or actions by competitors impact the whole supply chain in ways that are not easily understood or managed. Accelerating technology, the commoditization of healthcare, increasing demands from ageing populations all influence the approach that suppliers of pharmaceutical products and services worldwide need to take if they are to design and manage an effective supply chain that will be capable of: exploiting their intellectual property in a sustainable way; providing safe and continuous provision of drugs or devices; and sustaining with resilience, yet still be flexible and cost efficient. Supply Chain in the Pharmaceutical Industry offers the basis for organizations to develop their own blueprint for managing the opportunities and threats to the pharmaceutical supply chain. Using examples from companies and markets across the world Rob Whewell offers a very vivid picture of the developing trends for pharmaceutical companies; the customers and markets they serve and points to some of the elements that underpin sustainable pharmaceutical strategies. The current global banking and financial crisis illustrates the important role played by regulation. The healthcare industry is similar in scope, and complexity, yet the implications of error are worse - life threatening. This review of key industry parameters will provide senior executives in the industry and policy makers in healthcare with a broad perspective of the issues and illustrates an understanding of the task at hand.
Everybody knows—or thinks they know—Charles Darwin, the father of evolution and the man who altered the way we view our place in the world. But what most people do not know is that Darwin was on board the HMS Beagle as a geologist—on a mission to examine the land, not flora and fauna.Tracing Darwin’s footsteps in South America and beyond, geologist Rob Wesson sets out on a trek across the Andes, repeating the nautical surveys made by the Beagle’s crew, hunting for fossils in Uruguay and Argentina, and explores traces of long vanished glaciers in Scotland and Wales. By following Darwin’s path literally and intellectually, Rob experiences the landscape that absorbed Darwin, followed his reasoning about what he saw, and immerses himself in the same questions about the earth. Upon Darwin’s return from the five-year journey, he conceived his theory of tectonics—his first theory. These concepts and attitudes—the vastness of time; the enormous cumulative impact of almost imperceptibly slow change; change as a constant feature of the environment—underlie his subsequent discoveries in evolution. And this peculiar way of thinking remains vitally important today as we enter the Anthropocene.
A Dictionary of Human Geography is a brand new addition to Oxford's Paperback Reference Series, offering over 2,000 clear and concise entries on human geography terms. From basic terms and concepts to biographical entries, acronyms, organisations, and major periods and schools in the history of human geography, it provides up-to-date, accurate, and accessible information. It also includes entry-level web links that are listed and regularly updated on a dedicated companion website. This dictionary is a reliable reference for students of human geography and ancillary subjects, for researchers and professionals in the field, and for interested generalists.
An innovative book for an innovative topic." Charles Hampden-Turner Like the subject matter it covers, Clusters of Creativity is innovative and original. It breaks with popular interpretations of Silicon Valley and similar regions, which range from the hyperbolically laudatory to the contemptuously dismissive, and takes a critical, objective look at the lessons that these locations provide about innovation and entrepreneurship. Readable, yet rigorous in its analyses, the book provides a practical and balanced set of perspectives on how the powers of business creativity are fostered and sustained. It focuses not so much on the generations of high technologies but on the motivations and strategies of business leaders who turn revolutionary innovations into commercial realities. Clusters of Creativity demystifies the many enigmas that surround two leading capitals of the modern global economy, providing insights on managing innovation and entrepreneurship that are both eye-opening and broadly applicable to all organizations and industries. Clusters of Creativity will challenge assumptions, dispel myths, enlighten, inspire, and generally provoke thought. In an age where technology and hyperbole frequently go hand-in-hand, the book's well-founded insights are all the more refreshing and important.
The pharmaceutical and healthcare industry is hugely complex because it involves so many markets, products, processes and intermediaries. It is also heavily regulated, global, and used by everyone at some stage in their life. No wonder the supply chain for delivery of healthcare services is often fragmented and understood only in discrete sections. Changes in one area impact upon the others, and environmental factors such as pricing, regulatory change or actions by competitors impact the whole supply chain in ways that are not easily understood or managed. Accelerating technology, the commoditization of healthcare, increasing demands from ageing populations all influence the approach that suppliers of pharmaceutical products and services worldwide need to take if they are to design and manage an effective supply chain that will be capable of: exploiting their intellectual property in a sustainable way; providing safe and continuous provision of drugs or devices; and sustaining with resilience, yet still be flexible and cost efficient. Supply Chain in the Pharmaceutical Industry offers the basis for organizations to develop their own blueprint for managing the opportunities and threats to the pharmaceutical supply chain. Using examples from companies and markets across the world Rob Whewell offers a very vivid picture of the developing trends for pharmaceutical companies; the customers and markets they serve and points to some of the elements that underpin sustainable pharmaceutical strategies. The current global banking and financial crisis illustrates the important role played by regulation. The healthcare industry is similar in scope, and complexity, yet the implications of error are worse - life threatening. This review of key industry parameters will provide senior executives in the industry and policy makers in healthcare with a broad perspective of the issues and illustrates an understanding of the task at hand.
This will help us customize your experience to showcase the most relevant content to your age group
Please select from below
Login
Not registered?
Sign up
Already registered?
Success – Your message will goes here
We'd love to hear from you!
Thank you for visiting our website. Would you like to provide feedback on how we could improve your experience?
This site does not use any third party cookies with one exception — it uses cookies from Google to deliver its services and to analyze traffic.Learn More.